Brian Skorney
Stock Analyst at Robert W. Baird
(0.10)
# 4,812
Out of 5,125 analysts
836
Total ratings
34%
Success rate
-7.3%
Average return
Main Sectors:
Stocks Rated by Brian Skorney
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGNX REGENXBIO | Reiterated: Buy | $29 → $25 | $7.69 | +225.31% | 20 | Nov 6, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Hold | $20 → $18 | $16.40 | +9.76% | 109 | Nov 6, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $246 → $220 | $140.89 | +56.15% | 4 | Nov 3, 2026 | |
| REGN Regeneron Pharmaceuticals | Rated: Hold | $761 → $875 | $916.03 | -4.48% | 66 | Nov 2, 2026 | |
| BIIB Biogen | Reiterated: Buy | $250 → $290 | $253.32 | +14.48% | 98 | Oct 29, 2026 | |
| GILD Gilead Sciences | Reiterated: Hold | $145 | $170.91 | -15.16% | 82 | Oct 27, 2026 | |
| BHVN Biohaven | Reiterated: Buy | $52 → $48 | $15.12 | +217.46% | 14 | Oct 23, 2026 | |
| NRIX Nurix Therapeutics | Reiterated: Buy | $26 → $36 | $15.87 | +126.84% | 2 | Oct 13, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $123 → $130 | $94.54 | +37.51% | 45 | Sep 29, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $97 → $90 | $41.42 | +117.29% | 7 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $26 | $17.93 | +45.01% | 3 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $11.73 | +113.13% | 1 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $27 | $6.40 | +322.20% | 4 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $514 | $337.89 | +52.12% | 4 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $215 → $230 | $465.22 | -50.56% | 52 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $252 → $280 | $245.43 | +14.09% | 3 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $186 → $225 | $169.11 | +33.05% | 53 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $320 → $350 | $547.70 | -36.10% | 59 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $36 | $28.18 | +27.75% | 15 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $9.32 | n/a | 1 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $20 | $11.24 | n/a | 37 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $3.06 | n/a | 5 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $3.82 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $30 | $3.39 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $19.27 | n/a | 7 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 | $0.1834 | n/a | 14 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $35.71 | n/a | 16 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $21.35 | n/a | 14 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $9.32 | n/a | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $6.43 | n/a | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $39 | $1.16 | n/a | 6 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 → $146 | $11.16 | n/a | 5 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $1.83 | n/a | 11 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19.37 → $8.30 | $1.94 | n/a | 4 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $0.644 | n/a | 8 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $144 | $48.34 | n/a | 1 | Mar 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $83 → $138 | $424.44 | n/a | 5 | Feb 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $42 | $119.51 | n/a | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $57.11 | n/a | 11 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $13 | $19.08 | n/a | 7 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $2.47 | n/a | 3 | Jan 22, 2015 |
REGENXBIO
Nov 6, 2026
Reiterated: Buy
Price Target: $29 → $25
Current: $7.69
Upside: +225.31%
Sarepta Therapeutics
Nov 6, 2026
Reiterated: Hold
Price Target: $20 → $18
Current: $16.40
Upside: +9.76%
Axsome Therapeutics
Nov 3, 2026
Reiterated: Buy
Price Target: $246 → $220
Current: $140.89
Upside: +56.15%
Regeneron Pharmaceuticals
Nov 2, 2026
Rated: Hold
Price Target: $761 → $875
Current: $916.03
Upside: -4.48%
Biogen
Oct 29, 2026
Reiterated: Buy
Price Target: $250 → $290
Current: $253.32
Upside: +14.48%
Gilead Sciences
Oct 27, 2026
Reiterated: Hold
Price Target: $145
Current: $170.91
Upside: -15.16%
Biohaven
Oct 23, 2026
Reiterated: Buy
Price Target: $52 → $48
Current: $15.12
Upside: +217.46%
Nurix Therapeutics
Oct 13, 2026
Reiterated: Buy
Price Target: $26 → $36
Current: $15.87
Upside: +126.84%
Mirum Pharmaceuticals
Sep 29, 2026
Reiterated: Buy
Price Target: $123 → $130
Current: $94.54
Upside: +37.51%
Xenon Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: $97 → $90
Current: $41.42
Upside: +117.29%
Sep 9, 2026
Reiterated: Buy
Price Target: $32 → $26
Current: $17.93
Upside: +45.01%
Sep 3, 2026
Reiterated: Buy
Price Target: $25
Current: $11.73
Upside: +113.13%
Sep 1, 2026
Reiterated: Buy
Price Target: $17 → $27
Current: $6.40
Upside: +322.20%
Aug 7, 2026
Reiterated: Buy
Price Target: $400 → $514
Current: $337.89
Upside: +52.12%
Aug 5, 2026
Reiterated: Sell
Price Target: $215 → $230
Current: $465.22
Upside: -50.56%
Aug 4, 2026
Reiterated: Buy
Price Target: $252 → $280
Current: $245.43
Upside: +14.09%
Jul 31, 2026
Reiterated: Buy
Price Target: $186 → $225
Current: $169.11
Upside: +33.05%
Jul 7, 2026
Reiterated: Sell
Price Target: $320 → $350
Current: $547.70
Upside: -36.10%
May 18, 2026
Reiterated: Buy
Price Target: $38 → $36
Current: $28.18
Upside: +27.75%
Dec 12, 2024
Initiated Coverage: Buy
Price Target: $30
Current: $9.32
Upside: n/a
Nov 26, 2024
Reiterated: Buy
Price Target: $26 → $20
Current: $11.24
Upside: n/a
Nov 20, 2024
Reiterated: Buy
Price Target: $28
Current: $3.06
Upside: n/a
Nov 6, 2024
Reiterated: Hold
Price Target: $4
Current: $3.82
Upside: n/a
Dec 14, 2023
Downgraded: Hold
Price Target: $28 → $30
Current: $3.39
Upside: n/a
Nov 10, 2022
Reiterated: Buy
Price Target: $28
Current: $19.27
Upside: n/a
Nov 10, 2022
Reiterated: Hold
Price Target: $7.5
Current: $0.1834
Upside: n/a
Sep 8, 2022
Reiterated: Hold
Price Target: $6
Current: $35.71
Upside: n/a
Mar 31, 2022
Reiterated: Buy
Price Target: $15
Current: $21.35
Upside: n/a
Aug 12, 2021
Reiterated: Buy
Price Target: $16
Current: $9.32
Upside: n/a
Aug 12, 2021
Initiated Coverage: Buy
Price Target: $34
Current: $6.43
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $39
Current: $1.16
Upside: n/a
Aug 5, 2021
Reiterated: Hold
Price Target: $85 → $146
Current: $11.16
Upside: n/a
May 10, 2021
Reiterated: Hold
Price Target: $6
Current: $1.83
Upside: n/a
Jul 7, 2020
Reiterated: Buy
Price Target: $19.37 → $8.30
Current: $1.94
Upside: n/a
Nov 1, 2018
Reiterated: Buy
Price Target: $7 → $3
Current: $0.644
Upside: n/a
Mar 27, 2018
Reiterated: Buy
Price Target: $144
Current: $48.34
Upside: n/a
Feb 28, 2018
Reiterated: Hold
Price Target: $83 → $138
Current: $424.44
Upside: n/a
Jan 4, 2018
Reiterated: Buy
Price Target: $32 → $42
Current: $119.51
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $115
Current: $57.11
Upside: n/a
Jul 26, 2017
Reiterated: Hold
Price Target: $14 → $13
Current: $19.08
Upside: n/a
Jan 22, 2015
Reiterated: Buy
Price Target: $11
Current: $2.47
Upside: n/a